Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Filgrastim
Filgrastim – Granulocyte Colony-Stimulating Factor (G-CSF)
Filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) used to stimulate the production of neutrophils, a vital type of white blood cell. It is commonly used as supportive therapy in patients undergoing chemotherapy to reduce the risk of infection caused by low neutrophil counts (neutropenia).
Related products
-
Oncology Biosimilars
Pegfilgrastim
-
Oncology Biosimilars
Denosumab
-
Oncology Biosimilars
Rituximab
